3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Sarcoma, Synovial
2
Sarcoma
2
Liposarcoma
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Kaposi
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neurofibrosarcoma
1
Interventions
Temozolomide
45
Radiotherapy
20
Filgrastim
17
Carmustine
15
Carboplatin
15
Irinotecan
13
Bevacizumab
13
Magnetic Resonance Spectroscopy
12
Surgical Procedures, Operative
11
Peripheral Blood Stem Cell Transplantation
9
Erlotinib Hydrochloride
9
sargramostim
8
O(6)-benzylguanine
8
Radiation
7
Topotecan
6
Thiotepa
6
Radiotherapy, Intensity-Modulated
6
Procarbazine
6
Etoposide
6
Drug Therapy
6
Cyclophosphamide
6
Chemotherapy, Adjuvant
6
aldesleukin
5
Vorinostat
5
Sirolimus
5
Imatinib Mesylate
5
Granulocyte Colony-Stimulating Factor
5
Busulfan
5
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
5
temsirolimus
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Astrocytoma
×
Molecular Diagnostic Techniques
×
Sarcoma
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled